SCHEMBL4295558

SCHEMBL4295558

C1=Cc2ccccc2C2=C(NC3CCCCC3)CSC2=C1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
BCHE P06276 1/20 0.33
ACHE P22303 1/20 0.33
PRKCB P05771 1/20 0.31
HSD17B10 Q99714 1/20 0.31
NPC1 O15118 2/20 0.30
RAB9A P51151 2/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
HTT P42858 1/20 0.30
P2RX1 P51575 1/20 0.30
P2RX3 P56373 1/20 0.30
P2RX4 Q99571 1/20 0.30
P2RX7 Q99572 1/20 0.30
IDO1 P14902 1/20 0.30
MEN1 O00255 1/20 0.30
LMNA P02545 1/20 0.30
KMT2A Q03164 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4283739 0.81 MAOA (0.34) KDM4EMAPTHSD17B10NPC1RAB9A
SCHEMBL4286653 0.78 RAB9A (0.39) HSD17B10NPC1RAB9AL3MBTL1MEN1
SCHEMBL6835991 0.75 SETD7 (0.34) MAPTHSD17B10HTTMEN1LMNA
SCHEMBL4958302 0.71 SETD7 (0.35) MAPTHSD17B10HTTMEN1LMNA
SCHEMBL19690785 0.58
SCHEMBL11523761 0.57 KDM4E (0.73) KDM4EGAAMAPTBCHEACHE
SCHEMBL20336230 0.57 KDM4E (0.73) KDM4EGAAMAPTBCHEACHE
SCHEMBL4495740 0.57 KDM4E (0.73) KDM4EGAAMAPTBCHEACHE
SCHEMBL29449726 0.57 KDM4E (0.73) KDM4EGAAMAPTBCHEACHE
SCHEMBL24514268 0.55 KDM4E (0.53) KDM4EGAAMAPTHSD17B10NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8217001-B2 Modification of feeding behavior IMPERIAL INNOVATIONS LIMITED 2012-07-10 US disclosed
US-20090209461-A1 MODIFICATION OF FEEDING BEHAVIOR IMPERIAL COLLEGE INNOVATIONS LTD. (GB) 2009-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209461-A1 MODIFICATION OF FEEDING BEHAVIOR NPY4R, NPY5R, NPY2R KDM4E 2037/4885GAA 2226/4885MAPT 4603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.